top of page

Travelers Advised to Consider Mpox Vaccination

By V.E.K.Madhushani, Jadetimes News

 
Travelers Advised to Consider Mpox Vaccination.
Image Source : Michelle Roberts

Health Authorities Urge Precaution Amid Rising Cases in Affected Regions


Travelers heading to regions in Africa affected by mpox are being urged to consider getting vaccinated, according to updated guidance from the European Centre for Disease Prevention and Control (ECDC). This advice comes in response to outbreaks of a new strain of the virus, which may also lead to isolated cases in other continents, including Europe.

 

Despite the World Health Organization recently declaring the mpox situation a global emergency, the ECDC emphasizes that the overall risk of widespread transmission remains low. Mpox, formerly known as monkeypox, spreads through close contact with infected individuals and can cause flu like symptoms, skin lesions, and in some cases, can be fatal.

 

Those who have previously been vaccinated against mpox may only require a single booster dose rather than the full two shot series. Booster doses are typically recommended every two to ten years for those at continued risk of exposure.

 

The ECDC's updated recommendations highlight the ongoing situation in the Democratic Republic of the Congo (DRC), where at least 450 people have died in recent months due to a new variant, Clade 1b. This variant is raising concerns due to its potential to spread more easily and cause more severe illness.

 

ECDC’s Pamela Rendi Wagner stated, "Given the rapid spread of this outbreak in Africa, the ECDC has elevated the risk level for the general population in the EU/EEA and travelers to affected areas. Due to close links between Europe and Africa, we must be prepared for more imported Clade 1 cases."

 

Currently, no cases of Clade 1b mpox have been confirmed in the UK, but experts warn that international action is needed to prevent the spread. The ECDC advises public health authorities to be prepared for the quick detection and management of any future cases that may reach Europe.

 

Despite the availability of effective vaccines, there is a concern that not enough doses are reaching the regions where they are most needed.


More News

bottom of page